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ABSTRACT High-throughput screens allow us to understand how transcription factors trigger developmental processes, including cell
speciﬁcation. A major challenge is identiﬁcation of their binding sites because feedback loops and homeostatic interactions may mask
the direct impact of those factors in transcriptome analyses. Moreover, this approach dissects the downstream signaling cascades
and facilitates identiﬁcation of conserved transcriptional programs. Here we show the results and the validation of a DNA adenine
methyltransferase identiﬁcation (DamID) genome-wide screen that identiﬁes the direct targets of Glide/Gcm, a potent transcription factor
that controls glia, hemocyte, and tendon cell differentiation in Drosophila. The screen identiﬁes many genes that had not been previously
associated with Glide/Gcm and highlights three major signaling pathways interacting with Glide/Gcm: Notch, Hedgehog, and JAK/STAT,
which all involve feedback loops. Furthermore, the screen identiﬁes effector molecules that are necessary for cell-cell interactions during
late developmental processes and/or in ontogeny. Typically, immunoglobulin (Ig) domain–containing proteins control cell adhesion and
axonal navigation. This shows that early and transiently expressed fate determinants not only control other transcription factors that, in
turn, implement a speciﬁc developmental program but also directly affect late developmental events and cell function. Finally, while the
mammalian genome contains two orthologous Gcm genes, their function has been demonstrated in vertebrate-speciﬁc tissues, placenta,
and parathyroid glands, begging questions on the evolutionary conservation of the Gcm cascade in higher organisms. Here we provide
the ﬁrst evidence for the conservation of Gcm direct targets in humans. In sum, this work uncovers novel aspects of cell speciﬁcation and
sets the basis for further understanding of the role of conserved Gcm gene regulatory cascades.
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UNDERSTANDING the molecular signature of a develop-mental pathway is a major challenge in modern biology. Transcription factors specify cell fates by inducing the expres-sion of speciﬁc genes. For instance, the zinc ﬁnger transcrip-
tion factor glial cell deﬁcient/glial cellmissing (Glide/Gcm, or
Gcm for the sake of simplicity) is expressed transiently at early
stages (Bernardoni et al. 1997; Laneve et al. 2013; Flici et al.
2014) and controls Drosophila glial and blood development
(Hosoya et al. 1995; Jones et al. 1995; Vincent et al. 1996;
Bernardoni et al. 1997; Egger et al. 2002; Freeman et al.
2003; Soustelle et al. 2004; Altenhein et al. 2006). Gcm is
also expressed in tendon and peritracheal cells (Soustelle et al.
2004; Laneve et al. 2013), showing that fate determinants have
amuch broader role than expected and likely trigger the expres-
sion of target genes depending on the transcriptional and epi-
genetic environment of the different cell types. Expression
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proﬁling data and computational predictions were used previ-
ously to gain a better understanding of the Gcm regulatory
network (Egger et al. 2002; Freeman et al. 2003; Altenhein
et al. 2006), but these approaches did not allow genome-wide
identiﬁcation of the direct targets. Genes directly targeted by
transcription factors are commonly identiﬁed by chromatin im-
munoprecipitation (CHiP) using speciﬁc antibodies targeting
the transcription factors. Because no efﬁcient antibody is avail-
able for Gcm (Popkova et al. 2012; Laneve et al. 2013), we
decided to use DNA adenine methyltransferase identiﬁcation
(DamID) to identify the Gcm direct targets in Drosophila.
The DamID chromatin proﬁling is a methylation-based
taggingmethodused to identify the direct genomic loci bound
by transcription factors (van Steensel and Henikoff 2000; van
Steensel et al. 2001). The approach is based on the fusion of a
bacterial Dam methylase to a protein of interest to mark the
factor’s genomic binding sites by adenine methylation. The
DamID screen allowed us to identify 1031 targets, only some
of which have already been associated with a Gcm-dependent
cascade. Several targets belong to the Notch (N), JAK/STAT,
and Hedgehog (Hh) pathways and suggest the presence of
feedback loops. Because these pathways were previously shown
to affect the cell populations depending on Gcm, the DamID
data provide a molecular frame to clarify the observed mutant
phenotypes (Hosoya et al. 1995; Jones et al. 1995; Bernardoni
et al. 1997). The DamID screen also brought to light two key
features of the Gcm pathway.
First, we address the late role of fate determinants beyond
their ability to trigger novel transcriptional programs that are
subsequentlymaintainedby other factors [reviewed inCattenoz
and Giangrande (2015)]. The transiently expressed Gcm
transcription factor is known to induce the expression of
Reverse polarity (Repo), Tramtrack (Ttk), and Pointed (Pnt)
transcription factors that will ensure and maintain the glial-
speciﬁc differentiation program (Flici et al. 2014) [reviewed in
Cattenoz and Giangrande (2015)], and many Gcm targets
identiﬁed by the DamID screen code for transcription fac-
tors. In addition, however, we found a signiﬁcantly high
number of effector genes, including numerous members of
the Ig domain–containing protein family. These are mole-
cules that affect cell function or late developmental events,
including cell migration, a key feature of glia and hemocytes
(Schmucker et al. 2000; Watson et al. 2005; Kumar et al.
2015) [reviewed in Schwabe et al. 2009)]. This suggests
that early genes such as gcm may have a much broader
impact than expected in cell speciﬁcation/physiology.
Second, the Gcm pathway is conserved in evolution. The
Gcm protein is structurally conserved, as are most key de-
velopmental factors present in the ﬂy genome. Like the ﬂy
ortholog, murine mGcm1 (mGcm1) and mGcm2 are impor-
tant transcription factors because their deletion is lethal
(Anson-Cartwright et al. 2000; Gunther et al. 2000). How-
ever, the main role of the mammalian genes, including the
human genes, is, respectively, in the placenta and the para-
thyroid glands, two tissues that do not exist in invertebrates
(Kim et al. 1998; Basyuk et al. 1999, 2009; Gordon et al.
2001; Correa et al. 2002; Chen et al. 2004; Mannstadt et al.
2008, 2011; Doyle et al. 2012; Yi et al. 2012; Park et al. 2013;
Mitsui et al. 2014). The DamID data allow us to identify direct
targets that are common in ﬂies and vertebrates. To the best
of our knowledge, this is the ﬁrst evidence of functional con-
servation and sets the basis to further understand the Gcm
network in mammals.
Materials and Methods
DamID technique
The pUASTattB-NDam construct was made by cloning the
Dam-Myc cassette from pNDam-Myc (van Steensel and
Henikoff 2000; van Steensel et al. 2001), using EcoRI and
BglII, into pUASTattB. To produce the Dam-Gcm fusion con-
struct, the gcm full-length coding sequence was cloned into
pUASTattB-NDam (Choksi et al., 2006) using KpnI and NotI
sites. The two constructs were used to produce UAS Dam and
UAS Dam-Gcm ﬂies, respectively, employing the docking site
attP-22A (Bischof et al. 2007). Stage 10–11 embryos [4–7 hr
after egg laying (AEL)] were collected from the two strains.
DNA isolation, processing, and ampliﬁcation were performed
as described previously (Choksi et al., 2006). The Dam-only
and Dam-Gcm samples were labeled and hybridized together
on a whole-genome 2.1 million–feature tiling array with
50- to 75-mer oligonucleotides spaced at 55-bp intervals
(Nimblegen Systems). Arrays were scanned and intensities
extracted (Nimblegen Systems). Three biological replicates
(with one dye swap) were performed. Log2 ratios of each spot
were median normalized.
DamID analysis
A peak-ﬁnding algorithm with false-discovery-rate (FDR)
analysis was developed to identify signiﬁcant binding sites
(PERL script available on request). All peaks spanning eight or
more consecutive probes (900 bp) over a twofold ratio
change were assigned a FDR value. To assign a FDR value,
the frequency of a range of small peak heights (0.1–1.25 log2
increase) were calculated within a randomized data set (for
each chromosome arm) using 20 iterations for each peak size.
This was repeated for a range of peak widths (6–15 consec-
utive probes). All these data were used to model the expo-
nential decay of the FDR with respect to increasing peak
height and peak width, therefore enabling extrapolation of
FDR values for higher and broader peaks. This analysis was
performed independently for each replicate data set. Each
peak was assigned the highest FDR value from the three
replicates. Genes were deﬁned as targets where a binding
event (with FDR , 0.1%) occurred within 5 kb of the tran-
scriptional unit (depending on the proximity of adjacent
genes).
Conservation of the Gcm binding sites located in
DamID peaks
TheDrosophila genome (version BDGPR5/Dm3)was scanned
for the canonical Gcm binding sites (GBSs) listed in Figure 1B.
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For each GBS, the conservation score, which was calculated
from 12 Drosophila species, mosquito, honeybee, and red
ﬂour beetle (Blanchette et al. 2004; Siepel et al. 2005), was
taken from the Conservation track (multiz15way) on the
University of California Santa Cruz (UCSC) Genome Browser.
The GBSs locatedwithin 1 kb of DamID peakswere compared
with the whole population of GBSs (Figure 1E). An F-test was
used to compare the variance of the two populations, and
a t-test for unequal sample variance was used to calculate
the P-value.
Comparison with expression proﬁling data
The data set fromFreeman et al. (2003)was retrieved directly
from the publication. For Egger’s data set, the raw data were
retrieved and analyzed as described in the paper (Egger et al.
2002) (intensities .50 and fold change .1.5) with a more
restrictive P-value (,0.001). The data set from Altenhein
et al. (2006) comprising the ﬁltered and tested genes for
the gcm gain of function (GOF) and gcm loss of function
(LOF) was retrieved, and all genes giving nonspeciﬁc or neg-
ative in situ hybridizations (ISHs) were removed to make the
Venn diagrams in Figure 2. The R package VennDiagram was
used to draw the diagrams in Figure 2, B and C (Chen and
Boutros 2011). The gene names for all data sets then were
converted to FlyBase gene numbers (Fbgn) for comparison
with the DamID genes using the FlyBase conversion tool (dos
Santos et al. 2015).
Theexpressionproﬁles of theDamIDgeneswere compared
to the expression proﬁle of gcm in embryos using the in situ
data produced by the Berkeley Drosophila Genome Project on
embryos (Tomancak et al. 2002, 2007; Hammonds et al.
2013) (Table 1, Table 2, and Supporting Information, Table
S1, column O).
Fly strains and immunolabeling
Flies were raised on standard medium at 25. The follow-
ing strains were used: gcmGal4, UASmCD8GFP/CyO, Tb1
(gcmGal4, UASGFP in the text) (Soustelle and Giangrande
2007), y1v1; P(TRiP.JF01075)attP2 (UASgcmRNAi in the text)
(Bloomington B#31519), repoGal80 (gift of B. Altenhein),
and enGal4 (Bloomington B#30564) weres crossed with
Oregon R ﬂies to generate enGal4/+ or with UASgcm
F18A ﬂies (Bernardoni et al. 1998) to generate enGal4/+;
UASgcm/+ ﬂies (Figure 4), and gcmGal4, UASmCD8GFP
was recombinedwith repoGal80 to produce the line gcmGal4,
UASmCD8GFP, repoGal80/CyO. Overnight lays of Drosophila
embryos were used for Figure 4. In Figure 5, Drosophila cen-
tral nervous systems (CNSs) were dissected and labeled as
described previously (Ceron et al. 2001). The primary anti-
bodies used were rat anti-Ci [1:100; supernatant from the
Developmental Studies Hybridoma Bank (DSHB)], mouse
anti-Ptc (1:100; supernatant from the DSHB), mouse anti-
Smo (1:100; supernatant from the DSHB), rat anti-Elav
(1:200; supernatant from the DSHB), chicken anti-GFP
(1:1000; Abcam #13970), and rabbit anti-Dh31 [1:500;
kindly provided by J. Veenstra (Veenstra et al. 2008; Veenstra
2009)]. Secondary antibodies conjugated with FITC, Cy3,
or Cy5 (Jackson) were used at 1:500. DAPI was used at
100 ng/ml for nuclear counterstaining. Embryos and brains
were mounted in VECTASHIELD (Vector) mounting medium
and analyzed by confocal microscopy (Leica SP5) using iden-
tical settings between controls and mutants (gcm GOF and
hypomorph).
Gene Ontology (GO) term and protein domain
enrichment analysis
The GO term and protein domain enrichment analyses were
performed using the DAVID functional classiﬁcation tool
(Huang et al. 2009a,b).
Luciferase assay in S2 cells
For CG30002, CycA, E(spl)m8, and ptc (Figure 3, A–D), sense
and antisense oligonucleotides covering the GBSs in each
gene were synthesized with ﬂanking restriction sites for KpnI
at the 59 extremity and for NheI at the 39 extremity. Each pair
of oligonucleotides was designed with the wild-type (WT)
GBS and a mutated GBS that is not bound by Gcm (mutated
for nucleotides 2, 3, 6, and/or 7. In Table 3, the GBS and
restriction sites are indicated by capital letters. For each GBS,
the WT and mutant double-stranded probes were prepared
as follows: 1 nmol of forward probe and 1 nmol of reverse
probe were combined in 10 mM Tris, pH 7.5, 1 mM EDTA,
and 50 mM NaCl in 100 ml of total solution. The mix was
incubated for 1 min at 95 in a heating block, and then the
heating block was turned off and allowed to cool to 25. Then
2 mg of annealed oligonucleotides was digested with 20 units
of KpnI [New England Biolabs (NEB) #R3142S] and 20 units
of NheI (NEB #R3131S) in CutSmart buffer (NEB #B7204S)
for 90 min at 37. The digested double-stranded probes then
were cleaned using a PCRClean-UpKit [Macherey-Nagel (MN)
#740609] according to the manufacturer’s instructions.
Then 1 mg of luciferase reporter plasmid pGL4.23[luc2/
minP] (pGL4.23) (Promega #E841A) was digested with KpnI
and NheI as described previously; after 90 min at 37, 20
units of alkaline phosphatase, calf intestinal (CIP; Promega
#M0290S) was added to the plasmid and incubated for 1 hr
at 37. The plasmid then was cleaned using a PCR Clean-Up
Kit (MN #740609).
Then 50 ng of digested luciferase plasmid was combined
with the digested annealed probes (ratio plasmid/probe =
1:6), 400 units of ligase (NEB #M0202S), and ligation buffer
(NEB #B0202S) and incubated overnight at 18. The ligated
plasmids then were dialyzed for 30 min on membrane ﬁlters
(Millipore #VSWP02500) and ampliﬁed using the Plasmid
DNA Puriﬁcation Kit (MN #740410) according to the manu-
facturer’s instructions.
Transfections of Drosophila S2 cells were carried out in
12-well plates using Effectene transfection reagent (Qiagen
#301427) according to themanufacturer’s instructions. Cells
were transfected with 0.5 mg pPac-lacZ, 0.5 mg pGL4.23 car-
rying the indicated GBS, 0.5 mg pPac-gcm (Miller et al. 1998)
or 0.5 mg pPac (Krasnow et al. 1989). Then, 48 hr after
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transfection, cells were collected, washed once in cold
PBS, and resuspended in 100 ml of lysis buffer (25 mM
Tris-phosphate, pH 7.8, 2 mM EDTA, 1 mM DTT, 10% glyc-
erol, and 1% Triton X-100). The suspensions were frozen
and thawed four times in liquid nitrogen and centrifuged
for 30 min at 4 at 13,0003 g. The luciferase and LacZ activ-
ities were measured in triplicate for each sample. For LacZ
measurements, 20 ml of lysate was mixed with 50 ml of b-
galactosidase assay buffer (60 mM Na2PO4, 40 mM NaH2PO4,
10 mM KCl, 1 mM MgCl2, and 50 mM b-mercaptoethanol)
and 20 ml of ortho-nitrophenyl-b-galactoside (ONPG,
4 mg/ml) and incubated at 37 for 20 min. The reaction
was stopped by adding 50 ml of 1 M Na2CO3, and the optical
density at 415 nmwasmeasured. For luciferase activity, 10ml
of protein lysate was analyzed on an opaque 96-well plate
(Packard Instruments #6005290) with a Berthold Microlu-
minat LB96P Luminometer by injecting 50 ml of luciferase
buffer (20 mM Tris-phosphate, pH 7.8, 1 mM MgCl2, 2.5
mM MgSO4, 0.1 mM EDTA, 0.5 mM ATP, 0.5 mM luciferine,
0.3 mM coenzyme A, and 30 mM DTT). For both LacZ and
luciferase assays, background levels were estimated using ly-
sate from nontransfected S2 cells. The relative luciferase levels
were calculated as follows: ﬁrst, the background was sub-
tracted from each value, and then the average values of the
technical triplicate were calculated. From there, the lucifer-
ase activity of each sample was normalized to the LacZ
activity (luciferase activity/LacZ activity) to correct for
transfection efﬁciency variability, and the ratio luciferase
with Gcm/luciferase without Gcmwas calculated. For each
WT and mutant GBS, biological triplicates were carried
out.
S2 cell FACS and quantitative PCR (qPCR)
S2 cells were plated in six-well plates, 6 million cells per well,
in 1.5ml of Schneider medium complementedwith 10% fetal
calf serum (FCS) and 0.5% penicillin and 0.5% streptomycin
(PS).Cellswere transfected12hr after platingusingEffectene
Transfection Reagent (Qiagen). Brieﬂy, 2 mg of pPac-gal4
Table 1 Targets of Gcm involved in nervous system development
Gene symbol Annotation References
beat-Ia,a beat-Ib,a beat-IIIb,b beat-IIIc,b
beat-VI, beat-VII, btl, Dscam,b Dscam3,a
Dscam4, fas, Lar, Ptp99A, robo, robo2,
robo3,b Trim9,b tutlb
Axon guidance Seeger et al. (1993); Desai et al. (1996); Krueger et al. (1996);
Lekven et al. (1998); Rajagopalan et al. (2000);
Pipes et al. (2001); Sun et al. (2001); Jhaveri et al. (2004);
Hiramoto and Hiromi (2006); Al-Anzi and Wyman (2009);
Hofmeyer and Treisman (2009); Prakash et al. (2009);
Zeev-Ben-Mordehai et al. (2009); Song et al. (2011);
Armitage et al. (2012); Kim et al. (2013)
btl, fra,b sty, ths, unc-5 Axon ensheatment and glial
cell migration
Klambt et al. (1992); Shishido et al. (1997); Franzdottir et al.
(2009); von Hilchen et al. (2010); Mukherjee et al. (2012)
Atp-a, bib,b CG13248,b CG13384, CG30344,b
Fas2, Fas3,b Lac,b Sln, VGAT, wuna
Blood-brain barrier (amino acid
transport, septate junction)
Karlstrom et al. (1993); Strigini et al. (2006); DeSalvo et al.
(2014); Limmer et al. (2014); Deligiannaki et al. (2015)
Htlb Blood-brain barrier, axon
ensheatment, and glial
cell migration
Shishido et al. (1993); Shishido et al. (1997);
DeSalvo et al. (2014)
Babosb Dendritic plasticity Yuan et al. (2011)
Jbugb Epileptic seizure Goldstein and Gunawardena (2000); Song and Tanouye (2006)
CG13506,a ImpL2,b InR Insulin regulation Garbe et al. (1993); Claeys et al. (2002); Song et al. (2003);
Yuan et al. (2011); Sarraf-Zadeh et al. (2013)
gcm,b gcm2,b hkb,b loco,b pnt,b retnb Glial cell development Granderath et al. (1999); Kammerer and Giangrande (2001);
Shandala et al. (2003); Yuasa et al. (2003);
De Iaco et al. (2006); Popkova et al. (2012)
Dr,b vndb Late embryonic brain
development
Sprecher and Hirth (2006)
CycE,b Dl,b drk,b Egfr,b N,a Ras85Da Longitudinal glia precursor
division
Hidalgo et al. (2001); Grifﬁths and Hidalgo (2004);
Berger et al. (2005a,b); Thomas and van Meyel (2007)
brat,b E(spl)m5,b E(spl)m7,b E(spl)m8,b
E(spl)mb,b E(spl)md,b E(spl)mɣ,a
lola,b mira,b prosb
Neural stem cell regulation Neumuller et al. (2011); Carney et al. (2012);
Zacharioudaki et al. (2012)
ase,b ato,b ci,b d,b dally, ds, ft,b hbs,
hh, l(1)sc,b Pka-C1,a ptc, rdx,b
rho,b Ser, th,b tllb
Optic lobe development Gonzalez et al. (1989); Huang and Kunes (1996);
Rudolph et al. (1997); Huang and Kunes (1998);
Daniel et al. (1999); Chotard et al. (2005); Sugie et al. (2010);
Yasugi et al. (2010); Kawamori et al. (2011);
Perez-Gomez et al. (2013); Onel et al. (2014)
DIP-b,b DIP-u,a dpr11,a dpr15,a dpr2,
dpr3, dpr4, dpr5,b dpr8
Enriched in glia DeSalvo et al. (2014)
CG34371, CG42313, CG42389,
E(spl)m4, E(spl)m6, kek6, wakeb
Expressed in the CNS Bailey and Posakony (1995); Graveley et al. (2011)
a Genes not coexpressed in embryos according to the Berkeley Drosophila Genome Project in situ database. No mark for genes that were not assayed.
b Genes coexpressed in embryos with gcm. No mark for genes that were not assayed.
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vector and 1 mg of pUAS-GFP for the negative control and
2 mg of pPac-gcm (Miller et al. 1998) and 1 mg of 4.3kb repo-
GFP (repoGFP) (Laneve et al. 2013) for the gcm GOF were
mixed with 90 ml of EC buffer and 24 ml of enhancer and
incubated for 5 min at room temperature, and then 25 ml of
Effectene was added, and the mix was incubated at room tem-
perature for 20 min. Then 600 ml of Schneider medium +
10% FCS + 0.5% PS was added to the mix before spreading
it on the cells. At 48 hr after transfection, cells were sorted on
a BD FACSAria according to GFP expression to obtain more
than 80% of transfected cells in the sample. The RNA then
was extracted using TRI Reagent (Sigma), and 1 mg of
RNA per sample was DNAse treated with RNAse-free DNAse
1 (Thermo Fisher) and reverse transcribedwith Superscript II
(Invitrogen). qPCR was performed on a LightCycler 480
(Roche) with SYBR master (Roche) on the equivalent of
5 ng of reverse-transcribed RNA with the primer pairs listed
in Table S3. Each PCR was carried out in triplicate on at least
three biological replicates. The quantity of each transcript
was normalized to the quantity of the housekeeping genes
Glyceraldehyde 3 phosphate dehydrogenase 1 (Gapdh1) and
Actin 5c (Act5c). The P-values were measured comparing
the control with the transfected cells using Student’s t-test
(bars = SEM).
qPCR on gcm-overexpressing embryos
RNA extraction was carried out on 50 to 100 enGal4/+ or
enGal4/+; UASgcm/+ stage 13–14 embryos (at 25, 2 hr of
egg laying, 9 hr and 20 min of incubation before collection)
using TRI Reagent (Sigma). RNA extraction and qPCR were
performed as described for the S2 cells in triplicate.
Conversion to human orthologs
The Drosophila RNAi Screening Center (DRSC) integrative
ortholog prediction tool (Hu et al. 2011) was used to retrieve
the human orthologs of all Gcm targets identiﬁed in Drosoph-
ila by the DamID screen. All human genes with a weighted
score . 1 were selected.
qPCR in HeLa cells
HeLa cells were plated in six-well plates, 400,000 cells per
well, in 1.6 ml of Dulbecco’s Modiﬁcation of Eagle’s Medium
(DMEM) complemented with 5% FCS and gentamycin. Cells
were transfected 12 hr after plating using Effectene Trans-
fection Reagent (Qiagen). Brieﬂy, 1 mg of pCIG vector, 1 mg
of pCIG vector expressing mouse Gcm1 (pCIG-mGcm1)
(Soustelle et al. 2007), or 1 mg of pCIG vector expressing
mouse Gcm2 (pCIG-mGcm2) were mixed with 100 ml of EC
Table 2 Targets of Gcm involved in immune system development
Gene symbol Annotation References
att-ORFA, CanA1,a coro,b Crag,a dnr1,b dos,a
E2f1,b jumu,b loco,b lola,b mtd,b nub,b os,
par-1,a Pli, scny,a shg,b Stat92E,b tefu,
wun,a zfh1b
Antimicrobial humoral response
(response to fungi, response to
Gram-negative bacteria)
Kleino et al. (2005); Dijkers and O’Farrell (2007);
Kim et al. (2007); Jin et al. (2008);
Avadhanula et al. (2009); Cronin et al. (2009);
Guntermann et al. (2009); Petersen et al. (2012);
Wang et al. (2012); Dantoft et al. (2013);
Engel et al. (2014); Ji et al. (2014)
Atg18,b Atg5,a Atg8b,a Atg9,a hid,b Rab7a Autophagy Gorski et al. (2003); Hou et al. (2008);
Yano et al. (2008); Ren et al. (2009)
CG11313a Coagulation Karlsson et al. (2004)
if, sna Hemocyte migration Zanet et al. (2)009; Siekhaus et al. (2010)
alpha-Man-IIb, Gl,a Rac2,b RhoGEF3,b Zira Melanotic encapsulation of foreign targets Howell et al. (2012); Mortimer et al. (2012)
crq,b dally, DMAP1,a Dscam,b pnt,b Traf4b Phagocytosis Franc et al. (1999); Watson et al. (2005);
Stroschein-Stevenson et al. (2006);
Avet-Rochex et al. (2007); Zhu and Zhang (2013)
fz, fz2,b wg,b wntDb Wnt mediated inﬂammatory cascade Zhang and Carthew (1998); Gordon et al. (2005);
Sen and Ghosht (2008)
Alk, aop,a Egfr,b N,a Ras85Da Hemocytes proliferation Lebestky et al. (2003); Zettervall et al. (2004)
Antp,b Gale,b lolal,b mRpL53, pnr,b Ser, tupb Lymph gland development Lebestky et al. (2003); Mandal et al. (2004);
Han and Olson (2005); Mandal et al. (2007);
Tao et al. (2007); Mondal et al. (2014)
dpp, gcm,b gcm2,b htl,b l(3)mbn,a Pvf3,b ushb Plasmatocytes differentiation Konrad et al. (1994); Bernardoni et al. (1997);
Lebestky et al. (2000); Fossett et al. (2001);
Kammerer and Giangrande (2001);
Alfonso and Jones (2002); Cho et al. (2002);
Muratoglu et al. (2006); Frandsen et al. (2008);
Parsons and Foley (2013)
apt,b Pen, Ptp61F,b Socs36E,b Socs44Aa Repression of lamellocyte differentiation Kussel and Frasch (1995); Callus and
Mathey-Prevot (2002); Rawlings et al. (2004);
Baeg et al. (2005); Muller et al. (2005);
Sorrentino et al. (2007);
Starz-Gaiano et al. (2008); Stec et al. (2013)
a Genes not coexpressed in embryos according to the Berkeley Drosophila Genome Project in situ database. No mark for genes that were not assayed.
b Genes coexpressed in embryos with gcm. No mark for genes that were not assayed.
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buffer and 8 ml of enhancer and incubated for 5 min at room
temperature, and then 10 ml of Effectene was added, and
the mix was incubated at room temperature for 20 min. Then
200 ml of DMEM + 5% FCS + gentamycin was added to the
mix before spreading it on the cells, and 48 hr after transfec-
tion, the RNAwas extracted using TRI Reagent (Sigma). Then
1 mg of RNA per sample was DNAse treated with RNAse-free
DNAse 1 (Thermo Fisher) and reverse transcribed with Super-
script II (Invitrogen). qPCR was performed on a LightCycler
480 (Roche) with SYBR master (Roche) on the equivalent
of 5 ng of reverse-transcribed RNA with the primer pairs
listed in Table S3. Each PCR was carried out in triplicate on
at least three biological replicates. The quantity of each tran-
script was normalized to the quantity of the housekeeping
genes Glyceraldehyde 3 phosphate dehydrogenase (GAPDH)
and Actin Beta (ACTB). The P-values were measured compar-
ing the control with the transfected cells using Student’s
t-test (bars = SEM).
Luciferase assay in HeLa cells
For GCM1 and GCM2 (Figure 9), oligonucleotides surround-
ing the GBSs were designed with ﬂanking restriction sites for
KpnI at the 59 extremity and for NheI at the 39 extremity (in
Table 4, the GBS and restriction sites are indicated by lower-
case letters). Each pair of oligonucleotides was used to am-
plify the genomic region encompassing the GBSs on HeLa
genomic DNA using Expand High Fidelity System DNA poly-
merase (Roche). The amplicons were digested with 20 units
of KpnI (NEB #R3142S) and 20 units of NheI (NEB
#R3131S) in CutSmart buffer (NEB #B7204S) for 90 min
at 37. The digested amplicons then were cleaned using a
PCR Clean-Up Kit (MN #740609) according to the manufac-
turer’s instructions. Then 1 mg of luciferase reporter plas-
mid pGL4.23[luc2/minP] (pGL4.23) (Promega #E841A) was
digested with KpnI and NheI as described previously. After
90 min at 37, 20 units of CIP (Promega #M0290S) was
added to the plasmid and incubated for 1 hr at 37. The
plasmid then was cleaned using a PCR Clean-Up Kit (MN
#740609) according to the manufacturer’s instructions,
and 50 ng of digested luciferase plasmid was combined with
the digested amplicons (ratio of plasmid/probe = 1:6), 400
units of ligase (NEB #M0202S), and ligation buffer (NEB
#B0202S) and incubated overnight at 18. The ligated plas-
mids then were dialyzed for 30 min on membrane ﬁlters
(Millipore #VSWP02500) and ampliﬁed using the Plasmid
DNA Puriﬁcation Kit (MN #740410) according to the manu-
facturer’s instructions. These plasmids were used for the lu-
ciferase assay (Figure 9) and as templates for mutagenesis.
To mutagenize the reporters, primers overlapping the GBSs
were designed with mutations for nucleotides at position 2,
3, 6, and/or 7 in the GBSs (in Table 4, the GBS and restriction
sites are indicated by lowercase letters).
For each gene, PCR was performed using 5 ng of pGL4.23
containing the WT locus with Expand High Fidelity System
DNA polymerase (Roche). A ﬁrst round of PCRs was carried
out to generate the amplicon containing the ﬁrst and second
mutated GBSs and the amplicon containing the second
and third mutated GBSs with the following primer pairs:
GBS1mut forward/GBS2mut reverse and GBS2mut forward/
GBS3mut reverse. The two amplicons then were combined
using the primers GBS1mut forward and GBS3mut reverse
and inserted into pGL4.23.
Table 3 Oligonucleotides used to generate the pGL4.23 vectors used in S2 cells
Probe name Probe sequence
CG30002_GBS1_mutF gagaGGTACCtttgccgaaaaatgttcgggtAGTCGTTGcatacaatatccgctgaaacgGCTAGCgaga
CG30002_GBS1_mutR tctcGCTAGCcgtttcagcggatattgtatgCAACGACTacccgaacatttttcggcaaaGGTACCtctc
CG30002_GBS1_wtF gagaGGTACCtttgccgaaaaatgttcgggtATGCGGGCcatacaatatccgctgaaacgGCTAGCgaga
CG30002_GBS1_wtR tctcGCTAGCcgtttcagcggatattgtatgGCCCGCATacccgaacatttttcggcaaaGGTACCtctc
CG30002_GBS2_mutF gagaGGTACCtgtttgtgggcttgttctgaaaAGTCGTTGcagtgggttatgagaacaaaGCTAGCgaga
CG30002_GBS2_mutR tctcGCTAGCtttgttctcataacccactgCAACGACTtttcagaacaagcccacaaacaGGTACCtctc
CG30002_GBS2_wtF gagaGGTACCtgtttgtgggcttgttctgaaaATGCGGGAcagtgggttatgagaacaaaGCTAGCgaga
CG30002_GBS2_wtR tctcGCTAGCtttgttctcataacccactgTCCCGCATtttcagaacaagcccacaaacaGGTACCtctc
cycA_GBS_mutF gagaGGTACCctccacggccaacttggaattcCAACGACTcagctcatcgaattccgcctGCTAGCgaga
cycA_GBS_mutR tctcGCTAGCaggcggaattcgatgagctgAGTCGTTGgaattccaagttggccgtggagGGTACCtctc
cycA_GBS_wtF gagaGGTACCctccacggccaacttggaattcGCCCGCATcagctcatcgaattccgcctGCTAGCgaga
cycA_GBS_wtR tctcGCTAGCaggcggaattcgatgagctgATGCGGGCgaattccaagttggccgtggagGGTACCtctc
E(spl)m8_GBS_mutF gagaGGTACCatgctggagcgccagcgacgtCAACGACTgaacaagtgcctggacaacctGCTAGCgaga
E(spl)m8_GBS_mutR tctcGCTAGCaggttgtccaggcacttgttcAGTCGTTGacgtcgctggcgctccagcatGGTACCtctc
E(spl)m8_GBS_wtF gagaGGTACCatgctggagcgccagcgacgtGCCCGCATgaacaagtgcctggacaacctGCTAGCgaga
E(spl)m8_GBS_wtR tctcGCTAGCaggttgtccaggcacttgttcATGCGGGCacgtcgctggcgctccagcatGGTACCtctc
ptc_GBS1_mutF gagaGGTACCcatacacacacacacacacacCAACGACTcaacacacacacacacacgaaGCTAGCgaga
ptc_GBS1_mutR tctcGCTAGCttcgtgtgtgtgtgtgtgttgAGTCGTTGgtgtgtgtgtgtgtgtgtatgGGTACCtctc
ptc_GBS1_wtF gagaGGTACCcatacacacacacacacacacACACGCATcaacacacacacacacacgaaGCTAGCgaga
ptc_GBS1_wtR tctcGCTAGCttcgtgtgtgtgtgtgtgttgATGCGTGTgtgtgtgtgtgtgtgtgtatgGGTACCtctc
ptc_GBS2_mutF gagaGGTACCagcaggaagtgcaggatgctaCAACGACTaagtatgagtatcttccccatGCTAGCgaga
ptc_GBS2_mutR tctcGCTAGCatggggaagatactcatacttAGTCGTTGtagcatcctgcacttcctgctGGTACCtctc
ptc_GBS2_wtF gagaGGTACCagcaggaagtgcaggatgctaTCCCGCATaagtatgagtatcttccccatGCTAGCgaga
ptc_GBS2_wtR tctcGCTAGCatggggaagatactcatacttATGCGGGAtagcatcctgcacttcctgctGGTACCtctc
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HeLa cells were plated in 24-well plates, 60,000 cells per
well, in 350 ml of DMEM complemented with 5% FCS and
gentamycin. Cells were transfected 12 hr after plating using
Effectene Transfection Reagent (Qiagen). Brieﬂy, 2.5 ng of
pGL4.75 vector, 250 ng of pCIG vector expressing either
mouse Gcm1 (pCIG-mGcm1) (Soustelle et al. 2007) or mouse
Gcm2 (pCIG-mGcm2) or empty, and 250 ng of pGL4.23 vector
containing the GBS WT or mutant were mixed with 60 ml of
EC buffer and 4 ml of enhancer and incubated 5 min at room
temperature; then 5 ml of Effectene was added, and the mix
was incubated at room temperature for 20 min. Then 100 ml
of DMEM + 5% FCS + gentamycin was added to the mix
before spreading it on the cells, and 48 hr after transfection,
the luciferase assay was performed using the Dual-Luciferase
Reporter Assay System (Promega) according to the manufac-
turer’s instructions with a Berthold Microluminat LB96P
Luminometer.
Data availability
All data are joined with the publication in Supporting
Information.
Results
The DamID screen identiﬁes loci containing GBSs
To identify the genes directly regulated by Gcm, we mapped
its binding sites using a genome-wide DamID screen (van
Steensel andHenikoff 2000; van Steensel et al. 2001). Brieﬂy,
the Escherichia coli DNA adenine methyltransferase (Dam)
was fused N-terminal to the full-length Gcm coding se-
quences. Thus, wherever Gcm binds, the Dam methylates
the surrounding DNA. Themethylated DNA then can be iden-
tiﬁed by microarray. In our case, the Dam-Gcm screen was
performed on Drosophila embryos at stage 11, when Gcm
expression peaks. Because Gcm is expressed in several cell
types: glia, hemocytes, and tendon cells (Soustelle et al.
2004), as well as neuronal (Chotard et al. 2005; Soustelle
and Giangrande 2007) and peritracheal cell subsets (Laneve
et al. 2013), we decided to search for all its direct targets and
did not restrict expression of the Dam-Gcm fusion to a speciﬁc
cell type.
Overall, 4863 DamID peaks were identiﬁed. Motif enrich-
ment analysis using the MICRA tool (Southall and Brand
2009) revealed enrichment for the motif ATGCGGG at the
loci bound by the Dam-Gcm fusion (Figure 1A). This motif
is closely related to most of the GBSs previously described
and validated functionally (Figure 1B) (Akiyama et al. 1996;
Schreiber et al. 1997; Miller et al. 1998; Ragone et al. 2003).
Up to 83% of the loci identiﬁed in the screen contain canon-
ical a GBS(s) within 1 kb of the peak (Figure 1C), and the
average density of the GBS(s) present at the DamID peaks
(0.693 GBS/kb) is signiﬁcantly higher than the average GBS
density over the whole genome (0.138 GBS/kb) (P =
1.496 3 102148; Wilcoxon test = 0) (Figure 1D). Finally,
because numerous GBSs are present throughout the genome
but may not all be relevant to the Gcm cascade, we asked
whether those that are under a DamID peak aremore likely to
be directly associated with Gcm. Indeed, the GBSs present
under DamID peaks are signiﬁcantly more conserved than
the GBSs in the whole genome (12 Drosophila species, mos-
quito, honeybee, and red ﬂour beetle were used for the com-
parative analysis), thus adding strength to the DamID data
(P = 0.00273) (Figure 1E).
The DamID screen identiﬁes genes previously
characterized as Gcm interactors
The4863DamIDpeaks are located in thevicinity of (,5kb)or
within 1031 genes (Figure 1F shows the overall peak loca-
tions). To assess the speciﬁcity of the DamID screen, known
targets of Gcm were examined more closely. For instance,
gcm itself contains several GBSs upstream of its transcription
start site (TSS) and is known to autoregulate, and the stron-
gest GBS was determined previously to be GBS 3/C, which is
located 3 kb upstream of the gcm TSS (Miller et al. 1998;
Ragone et al. 2003) (Figure 2A). A DamID peak was detected
on top of this GBS (Figure 2A). Other examples include sna,
AGO1, brat, and lola, which were all identiﬁed as gcm inter-
actors in a genetic screen (Popkova et al. 2012) (Figure S1,
A–D). All of them contain at least one signiﬁcant DamID peak
in their promoter regions. Moreover, the gene loco involved in
late glial cell differentiation is controlled directly by Gcm
(Granderath et al. 2000) and has ﬁve canonical GBSs, three
of which are located within a DamID peak (Figure S1E).
Table 4 Oligonucleotides used to generate the pGL4.23 vectors used in HeLa cells
Probe name Probe sequence
GCM1 F GAGAggtaccCAGAGCCTGCTGGGACTTGA
GCM1 R TCTCgctagcTAGCTGGGATTACAGGCACG
GCM1 GBS1mut forward GAGAggtaccCAGAGCCTGCTGGGACTTGAaaaagacgTAAGATTTTCACGACACAGTGCTGT
GCM1 GBS2mut reverse GAACAGTAACGATATTGTCTcgtattttGCAAATTTTGTTATAACTAATTGGA
GCM1 GBS2mut forward TTAGTTATAACAAAATTTGCaaaatacgAGACAATATCGTTACTGTTCAGGGT
GCM1 GBS3mut reverse TCTCgctagcTAGCTGGGATTACAGGCACGccacaaaaCACCCAGCTAATTTTTGTATTTTCA
GCM2 F GAGAggtaccCAGGTAAGTGAACCGGGTGT
GCM2 R TCTCgctagcGGTAGAGACGGGGTTTCTCC
GCM2 GBS1mut forward GAGAggtaccCAGGTAAGTGAACCGGGTGTggtcgttcACGCGGGGCGCTGTCCATCCGAAGG
GCM2 GBS2mut reverse GCCTCAGAAACCCAGAAATTtgtcgtttATGTGTGTGTGTGTGTGTGTGTGTG
GCM2 GBS2mut forward ACACACACACACACACACATaaacgacaAATTTCTGGGTTTCTGAGGCCCTCT
GCM2 GBS3mut reverse TCTCgctagcGGTAGAGACGGGGTTTCTCCagttttttCAGGCTGGTCTTGAACTCCCGACCT
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Importantly, the three GBSs located under the peak are crit-
ical for the expression pattern of loco in glial cell (Granderath
et al. 2000). The gene pnt, involved in glial development
(Chen et al. 1992; Klambt 1993) and the immune response
(Zettervall et al. 2004), was described as downstream of gcm
(Giesen et al. 1997) and contains one canonical GBS within
one DamID peak (Figure S1F). Two other genes were exten-
sively described as targets of Gcm during glial cell develop-
ment: ttk and repo. Ttk is a transcriptional repressor
inhibiting the neuronal fate in neural stem cells (Giesen
et al. 1997). While containing two canonical GBSs within a
DamID peak, ttk was not identiﬁed as a direct target of Gcm
by our screen because the peak is located far (9.2 kb) from
the TSS (Figure S1G). The Repo homeodomain transcription
factor is required for the late differentiation of lateral glial
cells (Campbell et al. 1994; Xiong et al. 1994; Halter et al.
1995) and is directly activated by Gcm through the 11 GBSs
present in the 4.3-kb region upstream of the TSS (Lee and
Jones 2005). However, repo was not selected in our screen
because the observed DamID peak did not pass the enrich-
ment threshold to be considered signiﬁcant by the algorithm
(Figure S1H). This indicates that the criteria for the identiﬁ-
cation of the Gcm direct targets are extremely stringent.
Three teams had previously performed genome-wide
screens for the Gcm downstream targets (Egger et al. 2002;
Freeman et al. 2003; Altenhein et al. 2006). Egger et al.
(2002) compared WT stage 11 embryos to those expressing
Gcm ectopically in the neuroectoderm (GOF embryos) and
identiﬁed 356 genes signiﬁcantly enriched in gcm GOF
compared to WT animals (P , 0.001). Freeman et al. (2003)
combined computational prediction, expression proﬁling
analyses in WT and gcm GOF, and IHS in WT, gcm GOF,
and gcm LOF animals to identify and validate 48 genes as
downstream targets of Gcm. And ﬁnally, Altenhein et al.
(2006) tracked Gcm downstream targets in stage 9–16 em-
bryos in WT, gcm LOF, and gcm GOF animals and validated
119 genes by IHS. Together these studies identiﬁed 471
downstream targets of Gcm, but the overlap between the
three data sets is quite weak, with only 42 genes identiﬁed
by two of the studies and 5 genes identiﬁed by all three
studies (Figure 2B). Cross-referencing the three data sets
with the DamID peaks allowed us to considerably restrict
the number of targets identiﬁed by the expression proﬁling
analyses and revealed that 47 genes identiﬁed as down-
stream targets of Gcm in at least one of these studies are
direct targets of Gcm according to DamID (Figure 2, C and
D). Of note, in the ﬁrst part of their study, Freeman et al.
(2003) developed an algorithm to predict 384 direct targets
of Gcm based on the presence of a cluster of eight GBSs in the
surrounding regions. Among the predicted targets, only 8.3%
Figure 1 The DamID peaks are enriched for GBSs. (A) Schematic of the MICRA algorithm used to identify enriched motifs in the DamID peaks. For each
peak, 1000 nt of sequence was extracted and ﬁltered for conserved sequence, and then the frequency of every 6–10 mers was compared to the
background frequency in nonexonic DNA and ranked accordingly [for details, see Southall and Brand (2009)]. The most highly represented motif
corresponds to the canonical GBS. (B) Canonical GBS reported with the strength of Gcm binding and references. (C) Distance between the DamID peaks
and the closest canonical GBS. (D) Distribution of the number of canonical GBSs per kilobase in the whole genome and under the DamID peaks. The box
delimits the second and third quartiles; the thick black bar indicates the median for the two populations; the P-values are indicated as follows: ns =
nonsigniﬁcant (P . 0.05); *P = 0.05–0.01; **P = 0.01–0.001; ***P , 0.001. (E) Distribution of conservation scores of canonical GBSs in the whole
genome and under the DamID peaks. Box, thick black bar; asterisk, as in D. (F) Coding status of the genomic region covered by the DamID.
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(17 of 204 tested) were conﬁrmed in Gcm GOF or Gcm LOF
embryos (Freeman et al. 2003). Cross-referencing the DamID
data set with these bioinformatics data returned 47 genes of
384 (12%) predicted to be direct targets by the Freeman et al.
(2003) algorithm and conﬁrmed as direct targets by our
screen. Among these 47 genes, only 7 were previously vali-
dated in vivo (Table S1). Together with the observed evolu-
tionary conservation of the GBSs under DamID peaks, this
underlines the importance of scoring for occupied binding
sites.
Finally, expression proﬁling and DamID analyses provide
complementary information because the ﬁrst approach tells
the direct and indirect transcriptional consequences of a
mutation, whereas the second tells where the transcription
factor binds in the genome. We thus veriﬁed that the direct
targets identiﬁed in our screen are differentially represented
in the expression proﬁling data. Because expression of the
direct targets is induced just after Gcm starts being expressed
(stage 10), we expect them to be enriched in the expression
proﬁlingdata relative to theearly stages.Wethusanalyzed the
data of Altenhein et al. (2006) and found that for most of the
downregulated genes identiﬁed in the LOF expression pro-
ﬁling (119 in these data sets), expression starts being affected
over a large time window, between stages 11 and 13 (Figure
2E). In contrast, whenwe performed the same analysis on the
gene subset that also was detected in the DamID screen
(13 genes), we found that most of these targets start to be
downregulated at earlier stages (Figure 2F). Together these
ﬁndings indicate that the DamID screen is an efﬁcientmethod
to identify the direct targets of Gcm.
The DamID screen identiﬁes new direct targets of Gcm
Among the 1031 genes identiﬁed by the DamID screen, more
than 900 are new. The interaction betweenGcm and four new
Figure 2 Known targets of Gcm are found in the DamID screen. (A) Schematic representation of the gcm locus. The gene is indicated by the blue
rectangles, thin ones indicating the untranslated regions (UTR) and thick ones indicating the coding exons (CDSs); pale blue arrowheads indicate the
direction of transcription. In this and the following ﬁgures, GBSs are indicated in red, and the histograms above the locus show a region of 1 kb on each
side of a DamID peak scoring a FDR , 0.001. The histograms in gray indicate the nonsigniﬁcant DamID peaks with a FDR . 0.001. The genomic
coordinates of the loci (genome version BDGP R5/Dm3) are indicated above the histograms. (B) Euler diagram representing the overlap between the
downstream targets of Gcm identiﬁed by Altenhein et al. (2002), Freeman et al. (2003), and Egger et al. (2002). The size of each area is proportional to
the number of genes included in the category. (C) Subset of genes identiﬁed in the three transcriptome assays mentioned in B that are also identiﬁed as
direct targets by the DamID screen. The size of each area is proportional to the number of genes included in the category. (D) Names of the genes in
common between the screens of Altenhein et al. (2002), Freeman et al. (2003), and Egger et al. (2003) and the DamID. (E) Distribution of the genes
whose expression decreases in gcm LOF according to the earliest developmental stages at which they were identiﬁed [data set Altenhein et al. (2002)].
(F) Same distribution as in E but for genes present in both the DamID screen and the Altenhein et al. (2002) LOF data set.
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target genes was validated by luciferase assays in Drosophila
S2 cells. These genes were selected to be representative of
the different locations of the DamID peaks. They include
genes showing a DamID peak in the promoter and carrying
canonical GBS-like CG30002; genes for which the closest
GBSs are near the DamID peak but do not overlap with it,
such as CycA; and genes for which the DamID peak and the
GBSs are located within the transcribed region of the gene,
such as CycA, Enhancer of split m8 (E(spl)m8), and ptc. For
each gene, the regions containing the GBS under the DamID
peak or closest GBS to the DamID peak were cloned in a
luciferase reporter plasmid. For DamID peaks covering two
GBSs (CG30002 and ptc), one reporter was built per GBS.
The constructs then were transfected in S2 cells with or
without the Gcm expression vector ppacGcm. In parallel,
the same regions were mutated for their GBSs and analyzed
similarly (Figure 3, A–D). The gene CG30002 contains a
signiﬁcant DamID peak in its promoter region and two GBSs
at the position of the peak (Figure 3A). The luciferase assays
indicate that both GBSs induce transcription of the reporter
on cotransfection with Gcm, and no induction is observed
when the GBSs are mutated. Similar observations were
made on CycA, E(spl)m8, and ptc, even though the DamID
peaks are located within the coding sequences of these genes
(Figure 3, B—D).
To conﬁrm the data obtained with the reporter plasmids,
we analyzed the effects of Gcm on the endogenous genes and
measured the levels of their transcripts in S2 cells by qPCR.
S2 cells were transfected with ppacGcm because Gcm is
expressed at extremely low levels in those cells (Cherbas
et al. 2011). We were able to show signiﬁcant induction of
CycA and E(spl)m8 expression, but no induction was ob-
served for CG30002 or ptc (Figure 3E). Such a negative result
might be due to the facts that S2 cells do not contain the
appropriate cofactors, the genes are in a repressed chromatin
state, and/or S2 cells have low transfection efﬁciency. In-
deed, FACS analysis of S2 cells transfected with the Gal4
expression vector ppacGal4 and UAS-GFP vectors revealed
that only 4.92% of the cells express GFP. This means that
only a minority of the cell population contains the two plas-
mids (Figure 3, G and H). To improve the readout of the
assay, S2 cells were transfected with ppacGcm and the re-
porter plasmid repoGFP, which was used previously to trace
Gcm activity (Lee and Jones 2005; Laneve et al. 2013; Flici
et al. 2014). This allowed us to sort the cells that express the
GFP produced under the repo promoter. Based on the FACS
analysis, our transfection protocol allows the detection of
GFP in 2.11% of S2 cells (Figure 3I). These GFP+ cells were
enriched to reach at least 80% purity, and the preceding tar-
get genes were analyzed by qPCR. First, we monitored the
levels of repo endogenous transcripts to assess the efﬁciency
of our protocol. Without FACS sorting, no change in repo
levels was observable on Gcm expression, whereas we could
see a 30-fold increase on adding the FACS sorting step
(Figure 3F). This step also allowed us to detect the induction
of CG30002 and ptc expression (Figure 3F) and greatly
improved the detection of E(spl)m8 and CycA transcript
induction.
Finally, we tested DamID target genes in vivo. Because
ptc is strongly required in the epidermis at the level of
muscle attachment sites, where Gcm is also expressed and
required, we drove epithelial Gcm expression using the
engrailedGal4 (enGal4) driver (Figure 4I), which induces
expression of tendon cell markers (Soustelle et al. 2004).
Because several other members of the Hh pathway also
were identiﬁed in the DamID screen, including rdx, smo,
ci, and Pka-C1, we analyzed these genes as well. First, we
performed qPCR assays and found increased expression for
some of them (Pka-C1 and rdx) (Figure 4J). To comple-
ment this approach, we performed qualitative analyses
by immunolabeling on Gcm-overexpressing embryos and
found signiﬁcantly increased expression for Ptc, Ci, and
Smo (Figure 4, A–H9). In agreement with previously
obtained data (Soustelle et al. 2004), the expression of Re-
po did not increase, likely owing to the lack of cell-speciﬁc
factors, which are known to affect Gcm activity strongly (De
Iaco et al. 2006). Conversely, the expression of Repo in-
creases on overexpression of Gcm in the neurogenic region,
whereas that of Ci, Ptc, and Smo does not (data not shown).
In sum, the in vivo ﬁndings validate those in S2 cell trans-
fection assays, which thus provide a simple and sensitive
approach.
Moreover, the targets identiﬁed by the DamID screen are
not necessarily expressed in embryos at stage 11, the stage at
which the screen was performed. Indeed, comparison of
DamID and modENCODE transcriptome data on stage 10–
11 embryos reveals that 8.7% of the genes identiﬁed in our
screen are not expressed at this stage (Figure 3J). For exam-
ple, the Diuretic hormone 31 (Dh31) gene is not detected in
embryos on ISH (Tomancak et al. 2002, 2007; Hammonds
et al. 2013) and starts to be expressed at stage 17 according
to modENCODE data (Graveley et al. 2011). Nevertheless,
the Dh31 locus contains two DamID peaks, and Gcm induces
Dh31 expression in S2 cells (Figure 5A). We therefore ana-
lyzed later developmental stages and found colocalization of
Dh31 and Gcm in a single cell of the larval brain hemisphere
(Figure 5, B–C$). At that stage, Gcm is expressed in the de
novo–produced glial cells of the optic lobe, in the lamina, and
in medulla neurons (Chotard et al. 2005), as well as in two
groups of neurons of the central brain, the so-called dorso-
lateral andmedial clusters (Soustelle et al. 2007). The double
Gcm/Dh31+ cell belongs to the dorsolateral cluster, and
colocalization is affected in gcm mutant animals. The
gcmGal4, UASGFP line allowed us to trace gcm expression
in WT and hypomorphic conditions obtained by using
gcmGal4 homozygous or heterozygous animals carrying a
UASgcmRNAi construct (Figure 5, D–F). These data strongly
suggest that the Dam construct is present and can bind sites
in cells in which Gcm and/or its targets are not yet expressed.
In sum, we have shown that S2 cells can be used to validate
direct targets of Gcm on cell sorting, that the identiﬁed
targets are actually induced by Gcm in vivo, and that the
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Figure 3 Validation of new Gcm targets identiﬁed by the DamID screen. (A–D) The left panels represent the loci containing the DamID peaks and the
GBSs for CG30002 (A), CycA (B), E(spl)m8 (C), and ptc (D) (as described in Figure 2A), and the histograms on the right (in red) represent the results of the
luciferase assays carried out on each GBS. The red bars indicate enrichment of luciferase activity in the presence of Gcm compared to no transfected
Gcm (“no Gcm”); bars indicate SEM; and n represents the number of independent transfection assays. p-values are as indicated as Figure 1D. (E)
Histogram representing the endogenous levels of expression of CycA, E(spl)m8, CG30002, ptc, and repo in S2 cells with and without transfected Gcm.
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Dam-Gcm fusion likely identiﬁes most Gcm direct targets in
the ﬂy genome.
Protein domain enrichment analysis
To annotate the genes identiﬁed in the DamID screen, we ﬁrst
performedaproteindomainenrichment analysis usingDAVID
bioinformatics resources (Huang et al. 2009a,b). The analysis
showed enrichment for genes coding for proteins containing
basic Helix-Loop-Helix (bHLH) domains (17 genes) and Ho-
meobox domains (26 genes), which are characteristic of tran-
scription factors, but the most enriched family is the Ig
domain–containing protein (DAVID protein domain enrich-
ment: 7.79-fold; P = 1.3 3 10214; FDR = 2.0 3 10211)
(Figure 6A). Most of the Ig genes are involved in or at least
expressed during nervous system development (Figure 6B)
and code for guidance molecules [reviewed in Patel and Van
Vactor (2002)]. This includes two ﬁbroblast growth factor
receptors (Htl and Btl), two netrin receptors (Unc-5 and
Fra), six members of the Beaten path family (Beat), three
members of the Down syndrome cell adhesion molecule fam-
ily (Dscam), two fasciclins (Fas), three roundabout proteins
(Robo), and several others, including seven members of the
defective proboscis extension response family (Dpr) and two
Dpr interactors (Ozkan et al. 2013) (Figure 6B and Table 1).
The chemoreceptor family of genes dpr has been poorly char-
acterized so far, but these genes are also expressed in glial
cells (DeSalvo et al. 2014), suggesting that Gcmmay regulate
these genes during gliogenesis.
To conﬁrm induction of this class of genes by Gcm, the
levels of expression of 12 of them were assayed in S2 cells in
basal conditions or on transfection with a Gcm expression
vector (Figure 6C). The expression of 8 genes of 12 is signif-
icantly induced by Gcm in S2 cells, the strongest induction
being observed for htl (.100-fold increase) (Figure 6C).
GO term enrichment analysis
Gcm direct targets are involved in nervous system
development: Following protein domain enrichment analysis,
we carried out a GO term enrichment analysis for biological
function using DAVID. The analysis retrieved 230 genes in-
volved in nervous system development (8.8-fold enrichment;
P= 2.4310212; FDR= 3.93 1029). This subset of genes was
then further analyzed using an enrichment analysis for molec-
ular function. As expected from a cell fate determinant, the
major class of genes regulated by Gcm and involved in nervous
system development is transcription factors (67 genes; 6.7-fold
enrichment; P = 1.0 3 10232; FDR = 1.3 3 10229) (list in
Table S1, column J). More speciﬁcally, we found genes in-
volved in (1) neural stem cell (also called neuroblast) regula-
tion, (2) embryonic glial cell development, and (3) larval optic
lobe development (Figure 7A and Table 1).
1. Up to 34 genes regulate neural stem cells, including genes
that likely allow the transition from stem cell to glial iden-
tity. Interestingly, Pros also was identiﬁed as a positive
regulator of Gcm (Freeman and Doe 2001; Ragone et al.
2001; Choksi et al. 2006), and both Brat and Lola interact
with Gcm genetically (Popkova et al., 2012). These data
suggest the presence of feedback loops in the establish-
ment of glial fate.
2. Numerous targets are directly linked to glial cell develop-
ment, as expected given the gliogenic role of Gcm. For
example, Hkb controls glial subtype speciﬁcation by rein-
forcing Gcm autoregulation in a speciﬁc glial lineage and
interacts with Gcm genetically as well as biochemically
(De Iaco et al. 2006) (Popkova et al. 2012). In addition,
several genes are required in longitudinal glia precursor
division (Figure 7A and Table 1).
3. As to genes involved in optic lobe development, this is in
line with the ﬁnding that Gcm is necessary for both neu-
ronal and glial cell development within the larval optic
lobe (Chotard et al. 2005; Yoshida et al. 2005; Soustelle
et al. 2007). Of note, one of the targets, Tll, has been
shown recently to be necessary for speciﬁcation of lamina
neuronal precursors, showing a mutant phenotype similar
to that induced by the lack of Gcm (Guillermin et al. 2015).
Among the targets, we identiﬁed several members of
signaling pathways that control neural development at dif-
ferent steps: Hh, Egfr/Ras, and Fat/Hippo pathways (ft, Egfr,
Ras85D, rho, ds, d, CycE, th, and dally) and, ﬁnally, the N
pathway (N, Ser, Dl, l(1)sc, ase, and eight genes of the E
(spl) complex, or E(spl)-C). Because of their peculiar organi-
zation, we further validated the genes of E(spl)-C, which spans
over 50 kb and is located on the right arm of chromosome 3
(Figure 7, B andC). Itsmembers are all induced in FACS-sorted
S2 cells transfected with Gcm, whereas the gene directly adja-
cent to the complex, gro, is devoid of a DamID peak and is not
induced, indicating that Gcm activity is speciﬁc to the complex
(Figure 7C). N and Dl also were validated (Figure 8B).
Interestingly, several genes targetedbyGcmare involved in
the function of fully differentiated glia. Our screen identiﬁed
several genes acting in the blood-brain barrier (BBB) (Figure
7A and Table 1). Overlap between our screen and transcrip-
tome data of the BBB reveals that Gcm targets 61 genes
enriched in the BBB compared to all glial cells (Table S1,
column L) (DeSalvo et al. 2014; Limmer et al. 2014). Gcm
also targets several genes controlling axon ensheathment
and glial cell migration (Figure 7A and Table 1). In sum,
The y-axis is in log10 scale; error bars and P-values are calculated as indicated in Figure 3, A–D. (F) Same as E after FACS sorting of the Gcm+ cells. (G–I)
FACS analyses of S2 cells (G), of S2 cells transfected with the Gal4 expression vector ppacGal4 and the GFP reporter UAS-GFP (H), and of S2 cells
transfected with ppacGcm and repoGFP (I). The dotplots show the forward scatter area (FSC-A) on the y-axis and the GFP intensity on the x-axis. The
area in blue indicates the GFP+ cells that were sorted for further analysis, and the number under the area indicates the percentage of cells that are GFP+.
(J) Diagram representing the distribution of the DamID targets according to their levels of expression in stage 10–11 embryo (4- to 8-hr embryo in
modENCODE development RNA-seq).
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Figure 4 Gcm regulates the Hedgehog signaling pathway in the embryonic epidermis. (A–H) Immunolabeling of Ci (in gray), Ptc (in red), and Smo (in
green) in stage 15 embryos of the following genotypes: enGal4/+ (control) and enGal4/+; UASgcm/+ (gcm GOF). The areas delimited in white in A, C, E,
and G are magniﬁed in B–B$, D–D$, F and F9, and H and H9, respectively. Full projections of the embryos are shown in A, C, E, and G, and projections of
four optical sections taken at 2-mm interval are shown in the magniﬁed regions of B, D, F, and H. DAPI-labeled nuclei are in blue. Note that the three
proteins involved in the Hedgehog signaling pathway are expressed at higher levels in the gcm GOF than in the control embryo. Bar, 50 mm. (I and J)
Histograms showing the expression of gcm (I), ci, Pka-C1, and rdx (J) in enGal4/+ (control, red) and enGal4/+; UASgcm/+ (blue) embryos at stage 13–14.
The y-axis represents the relative expression levels compared to that observed in the control embryos (red columns). Error bars and the P-values are
calculated as in Figure 3D.
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Figure 5 Gcm overlaps with and regulates Dh31 expression in the larval CNS. (A) Histogram representing the endogenous expression levels of Dh31 in
S2 cells with and without transfected Gcm. Error bars and P-values are calculated as in Figure 3, A–D. (B–F$) Immunolabeling of Dh31 and GFP in larval
CNS (Dh31 in red; GFP in green). White arrowheads indicate cells coexpressing Dh31 and Gcm (GFP+ cells); asterisks indicate cells expressing only Dh31.
The gcm-expressing cells correspond to the dorsolateral neuronal cluster. Areas delimited in white in B and D are magniﬁed in C–C$ and E–E$,
respectively. (B) Full projection of a larval CNS of a heterozygous gcmGal4, UASmCD8GFP at the third instar. (C–C$) Projection of three optical sections
taken at 2-mm interval: (C) overlay of Dh31 and GFP, (C9) Dh31 alone, and (C$) GFP alone. (D–E$) Same as B–C$ in a gcmGal4, UASmCD8GFP
homozygous larva. (F–F$) Same as C–C$ in a gcm knockdown (KD) larva of the following genotype: gcmGal4, repoGal80, UASmCD8GFP/+; UASgcmR-
NAi/+. In all genotypes, the three sections contain the whole dorsolateral cluster (white oval). Note that in the gcmGal4 homozygous and in the gcm KD
(arrowheads) larvae, the intensity of Dh31 labeling is reduced in the GFP+ cell compared to that observed in the control gcmGal4 heterozygous animals.
Also take for comparison the surrounding Dh31+ cells (asterisk). (B and D) DAPI staining shows the nuclear labeling is in blue. Bar, 50 mm.
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the screen reveals the molecular role and mode of action of
Gcm in neural development and function.
Gcm direct targets are involved in immune system
development: In addition to its role in the nervous system,
Gcm is also required for differentiation and proliferation of
embryonic plasmatocytes. Embryos mutant for gcm and its
paralog gcm2 present a decreased number of plasmatocytes,
and the plasmatocytes do not complete the differentiation
process (Bernardoni et al. 1997; Alfonso and Jones 2002)
[reviewed in Kammerer and Giangrande (2001), Evans and
Banerjee (2003), and Waltzer et al. (2010)]. Plasmatocytes
are macrophages that can differentiate into another type of
hemocyte called a lamellocyte on immune challenge (Rizki
1957; Stofanko et al. 2010), a process that Gcm helps to re-
press (Jacques et al. 2009). The DamID screen identiﬁed 68
genes known to regulate the immune system (Figure 8A,
Table 2, and Table S1, columnM), and similar to the nervous
system, transcription factors are quite prominent (14 tran-
scription factors) (Table S1, column J).
In addition to gcm itself and gcm2 (Bernardoni et al. 1997;
Kammerer and Giangrande 2001; Alfonso and Jones 2002),
Gcm targets genes that promote the differentiation of prohe-
mocytes into plasmatocytes (Figure 8A and Table 2). Several
targets inhibit the JAK/STAT pathway, whose activation leads
to lamellocyte differentiation (Figure 8A and Table 2). Pen
and ush inhibit the formation of lamellocytes and so-called
melanotic tumors, which are masses of aggregated hemocytes
enriched in lamellocytes (Kussel and Frasch 1995; Sorrentino
et al. 2007). In addition, Gcm targets genes characterized by
their role in hemocyte proliferation or migration (Figure 8A
and Table 2).
Similar to the nervous system, Gcm also targets genes that
are involved in function of the mature immune system. These
include genes involved in (1) coagulation, (2) phagocytosis,
(3) autophagy, (4) the inﬂammatory cascade mediated by
Wnt, and (5) melanotic encapsulation of foreign targets
(Figure 8A and Table 2). Finally, DamID targets also include
genes that tune the immune response based on the nature
of the pathogen. Thus, based on the screen, Gcm induces
the expression of genes involved in the response to fungi,
in the response to gram-negative bacteria, and more broadly,
in the antimicrobial humoral response (Figure 8A and Table
2). In addition, we assayed 11 genes involved in hemocyte
biology using S2 cells transfected by a Gcm expression vector
and conﬁrmed the induction of 10 of them (Figure 8B).
Figure 6 Gcm targets encode Ig domain proteins. (A)
Histogram summarizing the protein domain enrichment
analysis. The x-axis indicates the enrichment score; the
grade of gray is representative of the P-value: lightest
gray, P = 1025; black, P = 10214. The y-axis indicates
the name of the protein domain; n indicates the number
of genes in the DamID screen containing that domain. (B)
List of genes from the DamID screen containing immuno-
globulin (Ig) domains. The genes indicated in green are
known to be involved in nervous system development; the
genes in blue are expressed in the nervous system. (C)
Histogram showing the endogenous expression of
Ig domain–containing genes on S2 cell transfection with
a Gcm expression vector and FACS sorting. The y-axis
represents the relative expression levels in cells transfected
with Gcm compared to cells without Gcm. The y-axis is in
log10 scale; error bars and p-values are calculated as in
Figure 3D.
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Gcm direct targets are involved in tendon cell and
peritracheal cell development: Tendons cells link muscles
to the backbone of the organism, and Gcm expression in these
cells is required for propermuscle attachment (Soustelle et al.
2004). Several Gcm targets are involved in the maturation
of tendon cells, such as Hh signaling pathway proteins Wg
and Egfr. The Hh signaling pathway and Wg are necessary
in the early development of tendon cells (Hatini and
Figure 7 Gcm targets involved in nervous
system development and function. (A)
List of DamID genes involved in neural
development and function. The genes
in red were previously characterized as
downstream targets of Gcm, and those
underlined were conﬁrmed by qPCR in
FACS-sorted S2 cells in this study. (B) Sche-
matic representation of E(spl)-C. Top panel
represents the DamID peak histogram on
the 0.8 Mb around E(spl)-C. Note that the
peaks are all localized within E(spl)-C. Bot-
tom panel shows the 50-kb window of E
(spl)-C. (C) Histogram represents the S2
cell endogenous levels of E(spl)-C tran-
scripts on transfection of a Gcm expression
vector, as indicated in Figure 3, A–D.
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DiNardo 2001), whereas the Egfr pathway promotes termi-
nal differentiation after the junction between the migrating
muscle and the tendon has been established (Yarnitzky et al.
1997).
Other targets expressed in tendon cells are directly in-
volved in muscle migration toward the tendon. Sli and Sdc
are guidance cues that attract themuscle (Kramer et al. 2001;
Steigemann et al. 2004). Leucine-rich tendon-speciﬁc protein
(Lrt) interacts with Robo expressed in the muscle to arrest
muscle migratory behavior (Wayburn and Volk 2009). Dnt
and Hbs control muscle attachment site selection (Dworak
et al. 2001; Lahaye et al. 2012). A third class of targets con-
trols the later step of building the junction between muscles
and tendons. Mew, If, Dys, and Wech are core components of
the junction (Prokop et al. 1998; Loer et al. 2008) [reviewed
in Charvet et al. (2012)]; Short stop (Shot) is an actin-tubulin
cross-linker involved in junction stabilization (Bottenberg
et al. 2009), and Sema-5C is a transmembrane protein so
far poorly characterized in tendon cells (Bahri et al. 2001).
Finally, Gcm is expressed in peritracheal cells (Laneve et al.
2013), endocrine cells located along the trachea that secrete
ecdysis-triggering hormone (O’Brien and Taghert 1998).
Only two markers of peritracheal cells have been character-
ized so far: the bHLH transcription factor Dimm (Hewes et al.
2003) and the neuropeptide biosynthetic enzyme peptidyl-
glycine-a-hydroxylating monooxygenase (Phm) (O’Brien
and Taghert 1998). Gcm acts upstream of dimm (Laneve
et al. 2013), and dimm is known to control the expression
of phm (Park et al. 2008), but neither dimm nor phm is pre-
sent in the DamID screen, suggesting that Gcm does not di-
rectly induce these genes in peritracheal cells. While little is
known about peritracheal cells, dimm and phm were further
characterized in neuroendocrine cells: 212 downstream tar-
gets of Dimmwere recently identiﬁed by combining CHiP and
transcriptome analyses (Hadzic et al. 2015). Comparison of
this data set with the DamID screen revealed that 27 targets
are common to Dimm and Gcm (Table S1), suggesting a
potential contribution of Gcm to the Dimm regulatory path-
way. In addition, based on our screen, Gcm targets a gene
involved in the endocrine function of Dimm+ cells: syt-b is
controlled by Dimm and is involved in calcium-dependent
exocytosis (Adolfsen et al. 2004; Park et al. 2014). To con-
clude, Gcm is necessary for the development of peritracheal
cells expressing Dimm, and our screen identiﬁed genes in-
volved in the Dimm pathway. This sets the stage for future
analysis of these genes in peritracheal cells. Overall, our
screen reveals the full extent of Gcm function in the diverse
cell types in which this transcription factor is expressed.
Figure 8 Gcm targets involved
in immune system development
and function. (A) List of the
DamID genes. Green area covers
those involved in immune system
function; red area covers those
involved in immune system devel-
opment. The genes in red were
previously characterized as down-
stream targets of Gcm, and those
underlined were conﬁrmed by
qPCR in FACS-sorted S2 cells in
this study. (B) Histogram repre-
senting the S2 cell endogenous
levels of genes involved in im-
mune system development on
transfection with a Gcm expres-
sion vector, as indicated in Figure
3, A–D.
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Conservation of the Gcm molecular cascade in mammals
Themammaliangenomecontains twoorthologsofDrosophila
gcm genes, which are named in humans GCM1 and GCM2.
GCM1 is required for differentiation of trophoblasts in the
developing placenta (Basyuk et al. 1999, 2009); GCM2 is
expressed and required mainly in the parathyroid glands
(Kim et al. 1998; Gordon et al. 2001). Because few targets
have been identiﬁed for GCM1 and GCM2, we sought for a
conserved Gcm regulatory cascade on retrieving themamma-
lian orthologs of the Drosophila targets identiﬁed in the
DamID screen (Table S1). To start a comparative analysis,
we chose genes that have a functional signiﬁcance in mam-
mals. A GO term enrichment analysis identiﬁed orthologs
that are associated with parathyroid gland or placenta devel-
opment, which allowed us to restrict the list to 29 genes
potentially targeted by GCM genes in mammals (Table S2).
We further analyzed the impact of murine Gcm genes on
GCM1 and GCM2; T-box transcription factor (TBX1); GATA3,
GATA4, andGATA6; FGFR1 and FGFR2; andDelta-like 1 (DLL1)
expression.
GCM genes regulate their own expression
GCM1 and GCM2 contain multiple GBSs in their promoters
(Figure 9, A and B). This suggests the existence of a positive-
feedback loop that has not been documented inmammals but
that is very well characterized for Drosophila gcm genes
(Miller et al. 1998; Ragone et al. 2003). To validate the autor-
egulation of GCM1 and GCM2 in mammals, we monitored
their levels of expression in HeLa cells transfected with ex-
pression vectors for mGcm1 and mGcm2. The use of mouse
orthologs allowed us to design qPCR primers speciﬁc for
the human transcripts and to speciﬁcally quantify their levels
of expression. This set of experiments shows that in HeLa
cells, GCM1 expression is induced by both mGcm1 and
mGcm2 (Figure 9C), and GCM2 is induced only by mGcm2
(Figure 9D).
To demonstrate that the induction of GCM1 and GCM2
expression was carried out via the GBSs, we arbitrarily se-
lected promoter fragments containing three GBSs with at
least 75% similarity with the canonical GBS ATG(A/C)GGG
(T/C) (Yu et al. 2002). These regions were cloned in lucifer-
ase reporters (Figure 9, A and B, red). For each region, we
also built the reporter with the mutated GBSs. The reporters
were then transfected in HeLa cells with or without mGcm1
or mGcm2. For GCM1, we could observe an induction by
mGcm1 and not by mGcm2, suggesting that the region
inserted in the reporter allows for Gcm1-mediated induction.
However, the three GBSs are not sufﬁcient for induction me-
diated by mGcm1 because their mutagenesis leaves it unaf-
fected (Figure 9E). Further scrutiny of the region revealed
the presence of two other GBSs with ,75% similarity with
the canonical GBS but still containing nucleotides 2, 3, 6, and
7, which were determined to be indispensable for Gcm bind-
ing (Schreiber et al. 1998). For GCM2, we showed that this
gene is able to induce expression of the luciferase reporter
carrying the GCM2 promoter and that this promoter is
inactive when the canonical GBSs are mutated (Figure 9F).
This demonstrates that GCM2 is able to regulate its own
expression via the GBSs inserted in the luciferase reporter.
To conclude, mGcm1 and mGcm2 induce GCM1 expression
via a region that has to be deﬁned, and mGcm2 activates
GCM2 transcription via a region covering the ﬁrst exon-
intron junction. These experiments demonstrate that positive
autoregulation is conserved between Drosophila and mam-
malian gcm genes.
Other DamID targets are conserved in mammals
TBX1 was shown previously to be coexpressed with GCM2
during formation of the parathyroid glands (Manley et al.
2004; Reeh et al. 2014) and contains 46 GBSs in its promoter.
To assess whether the GCM transcription factors are able to
induce TBX1 expression in mammals, we analyzed the levels
of TBX1 transcripts in HeLa cells transfected with expression
vectors coding for mouse orthologs mGcm1 or mGcm2. This
assay indicated that expression of TBX1 is speciﬁcally in-
duced by mGcm2 (Figure 9G).
The three GATA transcription factors GATA-3, GATA-4,
and GATA-6 control numerous developmental processes in
mammals [reviewed in Molkentin (2000), Cantor and Orkin
(2005), Zaytouni et al. (2011), and Chlon and Crispino
(2012)]. The three genes contain several GBSs in their pro-
moters, and expression of both GATA3 and GATA6 is induced
by mGcm2 in HeLa cells (Figure 9, H–J).
FGFR1 and FGFR2 are the mammalian orthologs of the
DamID targets btl and htl. FGFRs are widely described for
their roles in angiogenesis, cancer development, and organ-
ogenesis [reviewed in Bates (2011), Kelleher et al. (2013),
and Katoh and Nakagama (2014)]. They are also required for
building the placental vascular system and are expressed in
trophoblasts (Anteby et al. 2005; Pfarrer et al. 2006). Both
genes contain GBSs in their promoters. In HeLa cells, mGcm1
induces the expression of FGFR1, and mGcm2 induces the
expression of both FGFR1 and FGFR2 (Figure 9, K and L).
Finally, DLL1 is one of the ligands of the N receptor
(Shimizu et al. 2000). The N signaling pathway plays a crit-
ical role in cell fate determination [reviewed in Artavanis-
Tsakonas et al. (1999) and Schwanbeck et al. (2011)],
including trophoblast development (Zhao and Lin 2012;
Rayon et al. 2014; Massimiani et al. 2015), and DLL1 is
expressed in trophoblasts (Herr et al. 2011; Gasperowicz
et al. 2013). In humans, the DLL1 promoter contains GBSs,
and DLL1 expression is induced speciﬁcally by mGcm1 in
HeLa cells (Figure 9M).
The Drosophila orthologs of mammalian target genes
work in pathways known to depend on Gcm
The preceding data indicate that TBX1, GATA factors, the
FGFRs, and the N ligand DLL1 are regulated by Gcm in
mammals. As mentioned earlier, no tissue has been found
so far forwhichGcmfunction is required inbothmammalsand
Drosophila. This suggests that instead of a conservation of
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Figure 9 Conservation of Gcm targets in mammals. (A and B) Schematic representation of GCM1 (A) and GCM2 (B) loci in humans. The genes are
represented as in Figure 2A. GBSs are indicated as bars. The color coding refers to their similarity with the canonical GBSs used in mammals in Yu et al.
(2002) from 62.5% (blue) to 100% (red). The genomic coordinates of the loci (genome version GRCh37/hg19) are indicated above the GBSs. Red
rectangles indicate the regions used for the luciferase reporter assays, and the mutated sites are indicated by red asterisks. (C and D) Characterization of
mGcm1 and mGcm2 effects on GCM1 (C) and GCM2 expression (D). Histograms represent the endogenous expression levels of transcripts of each gene
in HeLa cells on transfection with mGcm1 or mGcm2; values are relative to those of housekeeping genes GAPDH and ACTB. (E) Histogram representing
the luciferase activity in HeLa cells transfected with mGcm1 or mGcm2 and luciferase reporters containing the region of GCM1 with WT or mutant
GBSs. Levels of luciferase activity are relative to those observed in the absence of mGcm transfection. (F) Histogram representing the luciferase activity in
HeLa cells transfected with mGcm2 and luciferase reporters containing the region of GCM2 with WT or mutant GBSs as in E. (G–M) Characterization of
mGcm1 and mGcm2 effects on TBX1 (G), GATA3 (H), GATA4 (I), GATA6 (J), FGFR1 (K), FGFR2 (L), and DLL1 expression (M), as in C and D. (N) Histogram
representing the S2 cell endogenous levels of Doc1, pnr, and btl on transfection with a Gcm expression vector, as indicated in Figure 3D.
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Gcm in similar tissues, we should look for conserved Gcm
cascades. To further test this hypothesis, we validated the
impact of Drosophila Gcm transcription factor on the Dro-
sophila orthologs of the four families of genes identiﬁed
earlier.
The Drosophila orthologs of TBX1 are the T-box transcrip-
tions factors Bi, H15 (Porsch et al. 1998), and Doc1, which
are required for ganglion mother cell (GMC) differentiation
during development of the embryonic nervous system (Choksi
et al. 2006; Leal et al. 2009). We validated the role of Gcm on
Doc1 in S2 cells (Figure 9N).
The Drosophila ortholog of the GATA factor Pnr regulates
postembryonic tendon cell differentiation (Ghazi et al. 2003).
There is a signiﬁcant induction of pnr expression by Gcm in
S2 cells (Figure 9N), but further experiments are required to
demonstrate the impact of Pnr on embryonic tendon cells or
the impact of Gcm on postembryonic tendon cells.
The ortholog of the FGFRs, htl, is involved in ensheathing
glia morphogenesis (Stork et al. 2014), and Gcm is required
for differentiation of these cells (Awasaki et al. 2008). Gcm
strongly induces expression of htl in S2 cells (Figure 6C). The
second ortholog, grn, presents the same expression pattern as
gcm in the developing embryonic CNS at stage 11 (Lin et al.
1995), indicating that Gcm may regulate grn expression in
this tissue.
Finally, the DLL1 Drosophila ortholog Dl is required as
part of the N pathway for the development of embryonic
glia (Udolph et al. 2001; Van de Bor and Giangrande 2001;
Umesono et al. 2002; Edenfeld et al. 2007), the larval optic
lobe (Egger et al. 2010; Yasugi et al. 2010; Wang et al. 2011),
and tendon cells (Nabel-Rosen et al. 1999; Ghazi et al. 2003).
Dl expression is induced by Gcm in S2 cells (Figure 8B).
Discussion
The DamID approach allowed us to identify the direct targets
of Gcm in Drosophila in a genome-wide fashion and to extend
these ﬁndings to mammals. It also allowed us to recognize
key molecular pathways and developmental processes that
depend on Gcm. The improvement of the transfection assays
on FACS sorting provides a rapid and sensitive tool to char-
acterize molecular pathways and genetic interactions. This
versatile approach is particularly useful to study genes that
are expressed at weak levels, in very few cells, or for which
the target tissues are still unknown.
Feedback loops between Gcm and signaling pathways
Gcm is widely described for its role in nervous system devel-
opment and hemocyte differentiation, and indeed, many of
the genes identiﬁed in the screen are involved in these two
processes (Table 1 and Table 2). The screen allowed us to
establish a direct link between Gcm and threemajor signaling
pathways, the vast majority of whose members are targeted
by Gcm.
The Hh pathway and Gcm are necessary for tendon cell
differentiation as well as for lamina neuron proliferation and
differentiation, but the relation between Gcm and the Hh
pathway remained vague (Chotard et al. 2005; Umetsu et al.
2006). Validation of the DamID screen in cells and in vivo
reveals that Gcm can control ﬁvemembers of the Hh pathway
(basically only Cos2 was not identiﬁed in the screen) (Figure
10A) at tendon cells. This includes Hh itself; its receptor, Ptc;
the proteins transducing the signal Smo, Pka-C1, and Ci; and
inhibitor of the signaling pathway Rdx. Interestingly, Chotard
et al. (2005) proposed that Gcm interacts with the Hh path-
way. Together with the ﬁnding that the Hh pathway is also
required upstream of Gcm in tendon cells for deﬁnition of
their precursor (Soustelle et al. 2004), these data suggest
the presence of a feedback loop.
The JAK/STAT signaling pathway triggers lamellocyte
differentiation [reviewed in Agaisse and Perrimon (2004)
and Myllymaki and Ramet (2014)] and was shown previ-
ously to be repressed by Gcm (Jacques et al. 2009). The
DamID screen shows the direct interaction between Gcm
and two major inhibitors of the JAK/STAT pathway, Ptp61F
and Socs36E, providing a molecular explanation for the ob-
served genetic interactions. Interestingly, Gcm also targets
Stat92E and Os (basically all the major players of the JAK/
STAT pathway were identiﬁed in the screen) (Figure 10B),
and the JAK/STAT pathway was shown to induce gcm expres-
sion in the optic lobe (Wang et al. 2013). This suggests the
existence of a feedback loop in this cascade as well.
Finally, the N pathway was described as an activator or
inhibitor of Gcm in glial cell differentiation depending on the
context (Udolph et al. 2001; Van de Bor and Giangrande
2001; Umesono et al. 2002). The DamID screen shows that
Gcm interacts with 30 genes of the N pathway, including
seven inhibitors and seven activators of that pathway (Table
S1); all the genes in the N pathway were found the in screen
(Figure 10C).
Thus, the DamID screen helps to clarify the impact of Gcm
on regulatory pathways at the molecular level and paves the
way for future studies assessing the biological relevance of
these interactions in vivo. These pathways had not been char-
acterized previously as regulated by Gcm, nor had they been
identiﬁed by the three transcriptome assays (Egger et al.
2002; Freeman et al. 2003; Altenhein et al. 2006). This is
most likely due to the fact that these pathways involve feed-
back loops and/or are required in most, if not all, tissues
during embryogenesis. Future studies will assess whether
Gcm targets different members of a signaling pathway in
speciﬁc tissues.
Gcm regulates genes organized in cluster
Analysis of the DamID screen reveals the regulation of
genes organized in a cluster, as illustrated by E(spl)-C. This
observation is in line with the hypothesis that chromatin
conformation plays an important role in transcription factor–
mediated induction of gene expression. Over a region of
0.8 Mb, the DamID peaks are exclusively concentrated in a
region of 50 kb that contains the 12 members of E(spl)-C
(Figure 7B), whose expression is upregulated by Gcm. In
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contrast, the unrelated gro gene is located at the boundary
of the complex, is not controlled by Gcm, and does not
contain a DamID peak (Figure 7C). The precise targeting
of Gcm to genes within the folded region of E(spl)-C corre-
lates well with chromosome conformation capture (3C) anal-
yses, which revealed long-range interactions within the
50-kb complex but very few interactions with regions sur-
rounding it (Schaaf et al. 2013). Further development of 3C
technology will allow full comprehension of the impact of the
chromatin three-dimensional structure on gene expression.
Gcm regulates genes required for the ﬁnal function of
differentiating tissue
Gcm is generally described as a cell fate determinant. Accord-
ingly, many Gcm direct targets are involved in the early
differentiation step, e.g., implementation of glial fate at the
expense of neuronal fate in the nervous system (Figure 7A
and Figure 8A, pink-shaded area). Surprisingly, a number of
genes identiﬁed by the screen are necessary at late develop-
mental stages or for function of fully differentiated cells
(Figure 7A and Figure 8A, green-shaded area). Typical ex-
amples are provided by the genes expressed speciﬁcally in
the BBB involved in amino acid, sugar, and water exchange
and by those coding for septate junction proteins, which are
necessary for the ﬁltering function of the BBB (Deligiannaki
et al. 2015) [reviewed in Hindle and Bainton (2014)].
Similarly, a number of genes acting in the immune system
are involved in antigen-speciﬁc immune response and the
encapsulation of foreign targets. Thus, an early and tran-
siently expressed gene directly targets genes involved in
physiologic responses. The fact is that early genes play a
broader role that initially was thought not to be so
Figure 10 Molecular pathways affected by Gcm. (A) Hedgehog signaling pathway. (B) JAK/STAT signaling pathway. (C) Notch signaling pathway. The
proteins and genes in black and red are targeted by Gcm, according to the DamID screen. The genes in red were previously characterized as
downstream targets of Gcm, and underlined genes were validated by qPCR in FACS-sorted S2 cells in this study. The proteins in gray are part of
the pathway but are not targeted by Gcm.
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uncommon because this was also observed for the transcrip-
tion factor Pros in the nervous system. Pros promotes the
switch from self-renewal to differentiation. DamID and tran-
scriptome analyses of the downstream targets of Pros
revealed that in addition to promoting genes involved in
repression of stem cell self-renewal, it also promotes expres-
sion of genes involved later on in terminally differentiated
neurons (Choksi et al. 2006).
Gcm downstream targets are conserved in mammals
The use of simple organisms such as Drosophila to understand
the GCM regulatory network in vertebrates has been limited to
few studies (Iwasaki et al. 2003; Soustelle and Giangrande
2007). This wasmostly due to the known requirement of mam-
malian Gcm genes in placenta or parathyroid glands, two tis-
sues that have no ﬂy equivalent. Despite the disparity of tissues
in which Gcm genes are expressed, we were able to ﬁnd con-
servation in the target genes. Because in humans GCM2 down-
regulation and mutations are associated with parathyroid
adenomas and hypoparathyroidism, respectively (Mannstadt
et al. 2008; Doyle et al. 2012; Yi et al. 2012; Park et al. 2013;
Mitsui et al. 2014), while GCM1 downregulation is associated
with preeclampsia (Chen et al. 2004), the downstream genes
identiﬁed in this work, including TBX1, GATA factors, and
FGFR, represent interesting candidates to dissect the molecular
mechanisms underlying these pathologies. Typically, TBX1mu-
tations in humans result in DiGeorge syndrome, which includes
parathyroid aplasia (Jerome and Papaioannou 2001; Merscher
et al. 2001). Also, GATA3 regulates GCM2 in the parathyroid
gland (Grigorieva et al. 2010), and GATA3, GATA4, and GATA6
are required during trophoblast development [reviewed by Bai
et al. (2013)]. Our data suggest a feedback loop betweenGCM2
and GATA3 in the parathyroid and point to a hitherto unknown
role ofGATA6 in this tissue, in line with recent immunolabeling
data (Uhlen et al. 2015). Finally, FGFR1 is misregulated in
hyperparathyroidism (Komaba et al. 2010).
Finally, the impact of Gcm on the N pathway seems to be
conserved to the largest extent. Of the 30 genes identiﬁed by
the screen, we conﬁrmed 9 by qPCR, including N, E(spl)-C,
and Dl. In humans, we show that DLL1 is regulated by GCM1,
and in the mouse, the E(spl)-C ortholog Hes5was reported to
be regulated by mGcm1 and mGcm2 (Hitoshi et al. 2011).
This gives strong support to the hypothesis that Gcm regu-
lates the N pathway in both Drosophila and mammals. How-
ever, the effect of Gcm most likely depends on the tissue.
Indeed, opposite outcomes have already been observed for
the effect of Notch on Gcm in Drosophila (Udolph et al. 2001;
Van de Bor and Giangrande 2001; Umesono et al. 2002), and
both activators and inhibitors of the N pathway were identiﬁed
in the DamID screen (Table S1). This means that the interac-
tion between Gcm and the N pathway will need to be studied
case by case. Overall, our data indicate that even though the
main sites of gcm expression may be different in mammals and
Drosophila, the Gcm cascade is at least partially conserved. In
this study, we discovered 980 new potential direct targets of
Gcm, demonstrated the direct interaction for 36 of them, and
the use of Drosophila allowed us to discover eight new targets
of the GCMs in humans, which include the characterization of a
feedback loop for GCMs on themselves.
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Figure S1: DamID peaks in genes previously identified as Gcm targets. Schematic representation of sna (A), AGO1 (B), brat (C), lola (D), loco (E), pnt 
(F), ttk (G) and repo (H) loci. The genes and the GBSs are indicated as in Figure 2. For loco (E), the numbers under the GBSs indicate the identity of the 
GBS as described in (GRANDERATH et al. 2000). 
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Table S2: Human orhtologs of Gcm targets
Human gene Drosophila ortholog tissue reference (DOI)
GCM2 gcm, gcm2 parathyroid (Liu et al., 2007)
PAX3 gsb, gsb-n, prd, toy parathyroid (Griffith et al., 2009)
SHH hh parathyroid (Grevellec et al., 2011)
SIX1 Six4 parathyroid (Zou et al., 2006)
SOX3 SoxN parathyroid (Bowl et al., 2005; Grigorieva and Thakker, 2011)
TBX1 bi, H15, Doc1 parathyroid (Reeh et al., 2014)
GATA3 grn, pnr parathyroid, trophoblast (Grigorieva et al., 2010; Bai et al., 2013); 10.1172/JCI42021
ADAM9 Meltrin trophoblast (Olson et al., 1998)
ASCL2 ac, sc, l(1)sc, ase trophoblast (Guillemot et al., 1994; Tanaka et al., 1997; Takao et al., 2012)
DLL1 Dl trophoblast (Sarikaya and Jerome-Majewska, 2011; Zhao and Lin, 2012)
DNAJB6 mrj trophoblast (Hunter et al., 1999)
FGFR1 btl, htl trophoblast (Ozawa et al., 2013)
FGFR2 btl, htl trophoblast (Ozawa et al., 2013)
FZD5 fz, fz2 trophoblast (Lu et al., 2013)
GAB1 dos trophoblast (Wang et al., 2004; Xie et al., 2005)
GATA4 grn, pnr trophoblast (Grigorieva et al., 2010)
GATA6 grn, pnr trophoblast (Grigorieva et al., 2010)
GCM1 gcm, gcm2 trophoblast (Hunter et al., 1999; Anson-Cartwright et al., 2000)
GRB2 drk trophoblast (Wang et al., 2004; Xie et al., 2005).
HRAS Ras85D trophoblast (Wang et al., 2004)
KLF6 luna trophoblast (Racca et al., 2011; Racca et al., 2014)
NR2F2 svp trophoblast (Hubert et al., 2010)
NR5A1 Hr39 trophoblast (Ben-Zimra et al., 2002)
RPS6KA1 S6k trophoblast (Wang et al., 2004)
RPS6KA2 S6k trophoblast (Wang et al., 2004)
RPS6KA3 S6k trophoblast (Wang et al., 2004).
SNAI1 sna trophoblast (Jordan et al., 2011)
SP1 Spps trophoblast (Degrelle et al., 2011; Takao et al., 2012)
TJP1 pyd trophoblast (Wang et al., 2008; Pidoux et al., 2010)
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Table S3: List of primers
specie gene Forward Reverse
drosophila Act5c GCCAGCAGTCGTCTAATCCA GACCATCACACCCTGGTGAC
human ACTNB ATGATGATATCGCCGCGCTC TCGATGGGGTACTTCAGGGT
drosophila Atg5 TCAGTTCTGGGCCGTCAATC TCCATTGCAGTTGGGTCTCC
drosophila babos AAGTGCTGACAGTGCTACCC AATCTGTGTCACACGGGACC
drosophila beat Ib CGATGTCGAGACTGCCCAAT TAACGTCCCCCAGACGGTAT
drosophila beat IIIb TGAGTTCTACCGCTATGTGCC TTCGGGGTCACCACAACAAT
drosophila btl AGGGAGTTTGTAGCCAAGCG TCGAGCGTTCTCCAGCTAAG
drosophila CG30002 GACCACGTTGTTTGGCAAGG AGTTAAGGCCTTCGGGTGAC
drosophila CycA TCTCGCCAACTGGAAGAGTC CTCCTCGGAAACCTCAACCA
drosophila Dh31 CAGTCAGCAGCAGTAACGGT TCCATTGGATTGGCTGGGC
drosophila Dl GACGAACAAGTCGGAATCGC GGCGCATTTGGGTATGTGAC
human DLL1 CACCGCTATGTGTGCGAGT CCTGGCCCTCTAGCTTCTCA
drosophila Doc1 CGTACTCCTCGAGATGGTGC GGCCAAAACGATATGTCCGC
drosophila dpr15 AAGCCACCGCCAACAATAGA GTCCTTCAGCTGCACGTACT
drosophila dpr2 AACCTGCGTGCGAAAATCAC GGCTTTCCCATCATCTCCCC
drosophila dpr3 CGACCCAAGGAAAGGCGTAA GCTAAGCGGACAAGAGCAAC
drosophila dpr4 TGCGCAACCGAATGTCAAAG TCCTGCCGGCTGTTGTATTT
drosophila E(spl)m2 TAACGTGTGGAAACCGCTGA ACTCCTCTGGCGTTGACTTG
drosophila E(spl)m3 GTGTGAGTGATCATGCGGGA GCAAACTAGTTCCCAGCCCT
drosophila E(spl)m4 GAAGCTGTCCTACAGCGTGA AGATGGAGGCGGATTCCAGA
drosophila E(spl)m5 GCAAACAGGTCGTCAAGCAG CCACATCCACACTCATGGCT
drosophila E(spl)m6 AGAACCAGGCAAACGAGAGG GCGGCTGTTGACATGATAGC
drosophila E(spl)m7 CTGGCGATGCCAAATTCGAG CACGGAAACTCTGTTCGGGA
drosophila E(spl)m8 AAACACTTGTCGCCGAGCTA ACCTCGTTGACGGCATTCAT
drosophila E(spl)mAlpha CCGAGATCGATGAGAACGCC GACTGGCTGAAGGTTGGTGG
drosophila E(spl)mBeta ATGGCTGCTGCTCACTTCTT CGCCCACTAAATGTCTGGGA
drosophila E(spl)mDelta GATACACCCAGGCTGCCTAC ATGGAATGCCCTTCACCAGG
drosophila E(spl)mGammaTCAGCCTAGGCACTCAGCTA CGATGGTGGTCAACAGGGAA
drosophila Egfr TGGATGAGCATATCGCGAGG TTGCTGACCGATGAGCTTGT
human FGFR1 GCCCAGACAACCTGCCTTAT CACGTATACTCCCCTGCGTC
human FGFR2 CACGACCAAGAAGCCAGACT GGTGTCTGCCGTTGAAGAGA
drosophila fz2 TGAAGAAAACCTGGGCGGAAT CGTCAAATCGTCAACGCTCG
drosophila Gapdh CCCAATGTCTCCGTTGTGGA TGGGTGTCGCTGAAGAAGTC
human GAPDH GAGAAGGCTGGGGCTCATTT AGTGATGGCATGGACTGTGG
human GATA3 GTTGTGCTCGGAGGGTTTCT GCACGCTGGTAGCTCATACA
human GATA4 GAAGGAGCCAGCCTAGCAG CTATTGGGGGCAGAAGACGG
human GATA6 TCGGGTCAAGATGGGCTCTA AAGCAGACACGAGTGGAGTG
human GCM1 CTGGTCCAAGGTGCTTGAGT ATAAGGTCAGGCCAGCCAAG
human GCM2 AGCTCAGCTGGGACATCAAC TGCTGTAGATGAAGCGCACA
drosophila gcm2 CCGGATCCGAAGAACTCCAG GTGTGAGCCAGAGGATTGCT
drosophila gro TTCAGCAACTTTTAATCCACGCC AGCGTGTGCGATACTTCTCA
drosophila hbs CTTCTGGTGGTGCAAACTGC AGCCGACTCAAAGTTCAGGG
drosophila htl AACGCCAAAAAGGTGTTGCAG GAGATGGCTGCTCGTGTGAT
drosophila Kaz-m1 CTTTGCTGCCTTGCATTGGT CTGCACGCTATTCCTTTCGC
drosophila Lac GCCAACTGATAGTGCCACCT CCACGTTGATATTGCGCCTG
drosophila Lar CCCTGCCAATTGGATCGGAA TCTCTGCGGGGGTACCATTA
drosophila loco CTGGCACCCACAATAGCAAAG GCCGGAATCATTCAGTTGGC
drosophila N GCACATGTGTCAACACCCAC CGAAACCTTTGGGGCACTTG
drosophila Pen CGACAAATTCTCGTGCTCGC TGCTGTTGGCCTTGTAGGAG
drosophila pnr GGAAGGATGGCATTCAGACCA GGTTTGAGATCATGCTCCTCCT
drosophila ptc TTCCGTCCGGAATCTGGCTA GTTTCGAGGTGGGACTGGAAT
drosophila Ptp61F GAAACTGCCCCACGTCAAAC CTTAAGGAATGCGTTCGGCG
drosophila repo CAGCCCAGTTATGTGCTTGC AACACTTTTGCCACTGCGAC
drosophila robo CGCCGTGAATCGCACTAAAG GGTGCTGTTGCAATGACGAC
drosophila Socs36E GTGTCCAACACCAGCTACGA GAGACCCGTATGTTGACCCC
drosophila Stat92E CTCGGTGGAGTCACTATCGC GGGCTCTTGACGCTTTGAGT
human TBX1 GTCTATGTGGACCCACGCAA GGTTCTGGTAGGCAGTGACC
drosophila ci AATGTCGCTCAGTCCACTCG TATGCGCTCGGCTTCCTAAG
drosophila Pka-C1 CAACTGTAACAGCCCCTCCC AAGGTTGTTCCGGCTTGTGT
drosophila rdx GGTTAACCCCAAGGGTCTCG CTTTGCCCTGCACAAAACGA
